Daré Bioscience, Inc. (DARE)

0.7734 0.00 (0.00%) USD  |  NASDAQ  |  Oct 09, 16:00
0.773 0.00 (0.00%) After-Hours: 20:00
More

Daré Bioscience Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for DARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 14, 2026 --
May 18, 2026 --
May 15, 2026 --
April 09, 2026 --
March 31, 2026 --
March 27, 2026 --
December 31, 2025 --
November 14, 2025 --
November 10, 2025 --
September 30, 2025 --
September 04, 2025 --
Date Value
August 18, 2025 --
August 16, 2025 --
July 15, 2025 --
June 30, 2025 --
June 05, 2025 --
May 14, 2025 --
April 03, 2025 --
March 31, 2025 --
December 16, 2024 --
November 15, 2024 --
August 15, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Elite Pharmaceuticals, Inc. --
Eton Pharmaceuticals, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade